Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.
Phase 2 Unknown
40 enrolled
PalboSarc
Phase 2 Unknown
40 enrolled
Chidamide Combined With Toripalimab in Sarcoma
Phase 2 Unknown
74 enrolled
Phase II Study of TAEST16001 in Soft Tissue Sarcoma
Phase 2 Unknown
70 enrolled
Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma
Phase 2 Unknown
48 enrolled
Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastatic Sarcoma
Phase 2 Unknown
50 enrolled
Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma
Phase 2 Unknown
70 enrolled
Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma
Phase 2 Unknown
47 enrolled
SYNERGIAS
Phase 2 Unknown
85 enrolled
HyperTET
Phase 2 Unknown
120 enrolled
Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma
Phase 2 Unknown
41 enrolled
Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma
Phase 2 Unknown
108 enrolled
A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue Sarcoma
Phase 2 Unknown
70 enrolled
Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue Sarcoma
Phase 2 Unknown
45 enrolled
UN-RESARC
Phase 2 Unknown
46 enrolled
The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma
Phase 2 Unknown
45 enrolled
A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS
Phase 2 Unknown
20 enrolled
PLD and IFO As First-line Treatment for Patients With Advanced or Metastatic STS
Phase 2 Unknown
40 enrolled
Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma
Phase 2 Unknown
120 enrolled
Study of SHR-1210 Combined With Apatinib in the Treatment of Sarcoma
Phase 2 Unknown
80 enrolled
Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma
Phase 2 Unknown
25 enrolled
LIPOMYX
Phase 2 Unknown
35 enrolled
ALTER-S001
Phase 2 Unknown
48 enrolled
CASPS
Phase 2 Unknown
36 enrolled
Anlotinib Hydrochloride For Advanced Soft Tissue Sarcoma Patients Who Do Not Receive Chemotherapy
Phase 2 Unknown
44 enrolled
PREMISS
Phase 2 Unknown
50 enrolled
Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors
Phase 2 Unknown
12 enrolled
RASS
Phase 2 Unknown
61 enrolled
A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma
Phase 2 Unknown
60 enrolled
Mesylate Apatinib for Stage â…£ STS After Failure of Chemotherapy
Phase 2 Unknown
80 enrolled
A Phase II Study of Apatinib in STS Patients
Phase 2 Unknown
53 enrolled
A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma
Phase 2 Unknown
30 enrolled
Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment
Phase 2 Unknown
70 enrolled
Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.
Phase 2 Unknown
35 enrolled
Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma
Phase 2 Unknown
118 enrolled
PICASSO
Phase 2 Unknown
67 enrolled
Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
Phase 2 Unknown
25 enrolled
Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
Phase 2 Unknown
25 enrolled
Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma
Phase 2 Unknown
27 enrolled
Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma
Phase 2 Unknown
Antiviral Therapy in Treating Patients With Slowly Progressing HIV-Related Kaposi's Sarcoma
Phase 2 Unknown
25 enrolled
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation
Phase 2 Unknown
80 enrolled
Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma
Phase 2 Unknown
41 enrolled
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma
Phase 2 Unknown
32 enrolled
Definitive Therapy for Oligometastatic Solid Malignancies
Phase 2 Unknown
110 enrolled
Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue Sarcomas
Phase 2 Unknown
20 enrolled
Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma
Phase 2 Unknown
30 enrolled
Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)
Phase 2 Unknown
117 enrolled
SSGXX
Phase 2 Unknown
188 enrolled
GVPS
Phase 2 Unknown
40 enrolled